-
1 week ago | 
today.westlaw.com | Shinjini Ganguli |Leroy Leo |Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 vaccine recommendations for the upcoming immunization campaign. The meeting comes after the appointment of Martin Makary...
-
1 week ago | 
today.westlaw.com | Leroy Leo |Siddhi Mahatole |Sriraj Kalluvila |Abhinav Parmar
(Reuters) - WW International, formerly known as WeightWatchers, said it plans to file for Chapter 11 bankruptcy protection on Tuesday, as the surging popularity of obesity drugs eroded demand for its traditional weight-loss programs.
-
1 week ago | 
dagenspharma.dk | Christy Santhosh |Leroy Leo
Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration May 5 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab said on Monday it will invest $40 billion in the U.S. over the next five years, as it seeks to expand its research and manufacturing presence in the country amid U.S. President Donald Trump's tariff threats.
-
1 week ago | 
today.westlaw.com | Leroy Leo |Christy Santhosh
(Reuters) -Bristol Myers Squibb said on Monday it will invest $40 billion in the U.S. over the next five years, as it seeks to expand its research and manufacturing presence in the country amid U.S. President Donald Trump's tariff threats.
-
1 week ago | 
today.westlaw.com | Stephen Coates |Urvi Dugar |Leroy Leo |Ryan Jones
(Reuters) -A Credit Suisse unit on Monday pleaded guilty to U.S. charges of helping ultra-wealthy Americans evade taxes and will pay a fine of more than $510 million, the U.S. Department of Justice said on Monday.
-
2 weeks ago | 
gurutrade.com | Ragini Mathur |Leroy Leo
FTSE 100 flat, FTSE 250 up 0.6%
Lloyds Banking Group falls on higher costs, impairment charges
Rolls-Royce rises on expectation to offset global tariff effects
British factory exports shrink sharply
May 1 (Reuters) - Britain's benchmark stock index was flat on Thursday as investors weighed a mixed bag of corporate earnings, a U.S.-Ukraine minerals deal, and hopes of a U.S. trade accord with China.
-
2 weeks ago | 
today.westlaw.com | Mariam Sunny |Alan Barona |Leroy Leo |Christy Santhosh
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening disorder, which is expected to bring in blockbuster revenues and drive growth. J&J had acquired the drug, to be sold...
-
2 weeks ago | 
today.westlaw.com | Alan Barona |Leroy Leo |Aatreyee Dasgupta |Aishwarya Jain
(Reuters) -Sabre Corp said on Monday it will sell its hospitality software platform to asset manager TPG for $1.1 billion and use the cash to pare its debt, lifting the travel technology provider's shares nearly 26% in early trading. The stock is now...
-
3 weeks ago | 
gurutrade.com | Sruthi Shankar |Leroy Leo
FTSE 100 down 0.2%, FTSE 250 down 0.2%
April 24 (Reuters) - British stocks dipped on Thursday as investors grappled with the Trump administration's shifting trade policies and parsed through quarterly reports for signs of a hit to company earnings from the ongoing trade war.
The blue-chip FTSE 100 and the midcap FTSE 250 indexes dipped 0.2% by 0954 GMT.
-
3 weeks ago | 
gurutrade.com | Sherin Sunny |Leroy Leo
April 21 (Reuters) - China's state-backed funds are pulling back from investing in the funds of U.S.-headquartered private capital firms amid an escalating trade war between the world's two biggest economies, the Financial Times reported on Monday.
Some of the Chinese funds are also seeking to be excluded from investments in U.S. companies made by private equity firms based elsewhere, the report, which cited seven private equity executives with knowledge of the matter, said.
